From October 1, 2022 to December 31, 2022, the company has repurchased 4,422,140 shares, representing 0.61% for CNY 27.49 million. With this, the company has completed the repurchase of 8,301,493 shares, representing 1.15% for CNY 56.25 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.73 CNY | +2.16% | +19.14% | -14.47% |
1st Jan change | Capi. | |
---|---|---|
-14.47% | 460M | |
+19.98% | 43.67B | |
+20.67% | 22.51B | |
+14.75% | 14.6B | |
+14.32% | 13.74B | |
+44.72% | 11.91B | |
-8.37% | 7.04B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.42B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on March 10, 2022.